Clinical Trial Technology Editorial
-
Can't-Miss Advice On Selecting Your First AI-Enabled Vendor
12/12/2025
Quarles & Brady's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.
-
The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
12/10/2025
Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry.
-
From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
12/3/2025
Discover how pharma R&D is moving from traditional compute clusters to AI-driven HPC ecosystems and hybrid architectures that combine on-premise supercomputing with elastic cloud infrastructure.
-
Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
11/18/2025
Discover how to establish a holistic AI-led digital strategy, starting with a top-down, phased approach.
-
How AI Is Transforming Patient Stratification
10/31/2025
Discover how AI tools can help stratify or group patients into subtypes that respond differently to treatment.
-
How AI Is Rewriting The Future Of TMF And Clinical Quality
10/29/2025
Discover how AI is transforming the TMF from a reactive repository into a proactive, intelligent co-pilot for clinical trials.
-
Clinical Trials At A Crossroads
10/22/2025
At DPHARM 2025, McKinsey’s Gaurav Agrawal warned that while clinical science is accelerating, trial operations aren’t keeping pace. He outlined a vision for 2035 built on scaling AI, expanding site ecosystems, and bringing trials closer to everyday patient care.
-
Whole-Body MRI Biomarkers Unlock A Fuller Picture In Neuromuscular Trials
10/15/2025
Discover the utility and promise of whole-body MRIs a digital biomarkers in neuromuscular clinical trials.
-
What Sites Wish Tech Vendors (And Sponsors) Heard At SCDM But Probably Didn't
10/8/2025
During a Society for Clinical Data Management (SCDM) panel discussion, three site-side representatives discussed the challenges clinical research coordinators have executing their clinical duties amid increasingly complex data entry demands.
-
How One Biopharma Company Overcame Trial Failure
10/6/2025
PolyPid's Eyal Shoshani highlights the company's second attempt at its SHIELD trial, including things they did to revamp the trial design and the impact of AI in this and future trials.